We encourage our employees to dream
Then we give them the freedom to reach those dreams
We create innovations for the WORLD
Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, and nephrology. OCPI is dedicated to improving patients’ health and the quality of human life.
Start a new Story at Otsuka
Come and work with a team of people who aren’t afraid to challenge convention. This approach can lead to something new, something better.
We aspire to attract best-in-class people and partners. After all, having the right team makes all the difference.
We encourage our employees to dream. Then we give them the freedom to reach for those dreams.
What is your story going to be?
Montreal, Canada, January 24, 2024
Health Canada Approves Otsuka and Lundbeck’s REXULTI® (brexpiprazole) for the Symptomatic Management of Agitation Associated with Alzheimer’s Dementia
tsuka Pharmaceutical Canada Inc. (Otsuka) and Lundbeck Canada Inc. (Lundbeck) announce that Health Canada has issued a Notice of Compliance for REXULTI® (brexpiprazole) for use in the symptomatic management of agitation associated with Alzheimer’s dementia (AAD) in patients with aggressive behaviour, unresponsive to non-pharmacological approaches.
Read the press release
Who We Are
2250 Alfred-Nobel Boulevard,
Droits d'auteur Otsuka. Tous droits réservés.
L'information contenue sur ce site s'adresse exclusivement aux Canadiens